BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...CSE:LUN) Abide Therapeutics Inc. 05/06/19 $250.0 NA $150.00 $400.0 WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) Pharmapace Inc....
BioCentury | Jun 25, 2019
Company News

WuXi AppTec raising U.S. profile to counter political attacks

...enhancing its core business, Hu said. Its most recent deal was the May acquisition of Pharmapace Inc....
BioCentury | May 6, 2019
Company News

May 6 Company Quick Takes: Esperion, BioMarin, WuXi AppTec, Axsome, Harbour BioMed/CTTQ, GW, Adynxx

...its biometrics capabilities in the U.S. and Europe, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) acquired Pharmapace Inc....
Items per page:
1 - 3 of 3
BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...CSE:LUN) Abide Therapeutics Inc. 05/06/19 $250.0 NA $150.00 $400.0 WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) Pharmapace Inc....
BioCentury | Jun 25, 2019
Company News

WuXi AppTec raising U.S. profile to counter political attacks

...enhancing its core business, Hu said. Its most recent deal was the May acquisition of Pharmapace Inc....
BioCentury | May 6, 2019
Company News

May 6 Company Quick Takes: Esperion, BioMarin, WuXi AppTec, Axsome, Harbour BioMed/CTTQ, GW, Adynxx

...its biometrics capabilities in the U.S. and Europe, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) acquired Pharmapace Inc....
Items per page:
1 - 3 of 3